PTC Therapeutics Inc [PTCT] Shares Fall -0.51 % on Wednesday
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. PTC Therapeutics Inc shares valued at $14,923 were sold by Golden Lee Scott on Apr 02 ’24. At $28.37 per share, Golden Lee Scott sold 526 shares. The insider’s holdings dropped […]
Morgan Stanley gives an Underweight recommendation for PTC Therapeutics Inc (PTCT)
PTC Therapeutics Inc’s recently made public that its EVP & CHIEF MEDICAL OFFICER Golden Lee Scott unloaded Company’s shares for reported $14923.0 on Apr 02 ’24. In the deal valued at $28.37 per share,526 shares were sold. As a result of this transaction, Golden Lee Scott now holds 59,988 shares worth roughly $1.58 million. Then, […]
Examining the Potential Price Growth of PTC Therapeutics Inc (PTCT)
In a filing, PTC Therapeutics Inc revealed its EVP & CHIEF MEDICAL OFFICER Golden Lee Scott unloaded Company’s shares for reported $14923.0 on Apr 02 ’24. In the deal valued at $28.37 per share,526 shares were sold. As a result of this transaction, Golden Lee Scott now holds 59,988 shares worth roughly $1.66 million. Then, […]
PTCT Stock Sees Decline of Approximately -5.50% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. PTC Therapeutics Inc shares valued at $14,923 were sold by Golden Lee Scott on Apr 02 ’24. At $28.37 per share, Golden Lee Scott sold 526 shares. The insider’s holdings dropped […]
A company insider recently sold 794 shares of PTC Therapeutics Inc [PTCT]. Should You also Consider to Sale?
In a filing, PTC Therapeutics Inc revealed its EXEC. VP AND CLO Boulding Mark Elliott unloaded Company’s shares for reported $21637.0 on Jan 30 ’24. In the deal valued at $27.25 per share,794 shares were sold. As a result of this transaction, Boulding Mark Elliott now holds 71,189 shares worth roughly $2.04 million. Then, Almstead […]
Morgan Stanley’s latest rating for PTCT stock
PTC Therapeutics Inc’s recent filing unveils that its EXEC. VP AND CLO Boulding Mark Elliott unloaded Company’s shares for reported $21637.0 on Jan 30 ’24. In the deal valued at $27.25 per share,794 shares were sold. As a result of this transaction, Boulding Mark Elliott now holds 71,189 shares worth roughly $1.99 million. Then, Almstead […]
